Most of the current research and development (R&D) surrounding cannabis revolves around understanding these biologically-active ingredients, especially cannabinoids.
Most of the current research and development (R&D) surrounding cannabis revolves around understanding these biologically-active ingredients, especially cannabinoids.
Investors have had their eyes on Algae Dynamics Corp. (OTCQB: ADYNF), which has partnered with various Canadian universities (including the University of Waterloo and Western University) for access to research and to boost its cannabis extraction expertise.
With so many medically beneficial applications, its little wonder that Algae Dynamics Corp. (OTC: ADYNF) has focused on commercialization of its proprietary BiloSilo™ system for the high volume, low cost production of contaminant-free algae biomass.
Algae Dynamics Corp. (OTCQB: ADYNF) is uniquely positioned to take advantage of the full legalization of cannabis in Canada by leveraging its expertise and experience with algae oil extraction to expand into the Canadian cannabis oil marketplace.
On Monday, January 30, 2017, Alan Klitenic, the Director of Investor Relations for ChineseInvestors.com, Inc. (OTCQB: CIIX), was interviewed by NetworkNewsWire.
Alzheimer’s disease is a devastating brain disorder that now affects about 5.3 million Americans, accounting for one in nine people over the age of 65, according to the Alzheimer’s Association.
With the market expanding and public support increasing, there are more opportunities to invest than ever before.
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) this morning provided an update on its construction and expansion timelines for its Vanluven and Kimmett facilities, both of which are located in Napanee, Ontario.
Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC)
Combination therapies that use cannabis-based pain reduction methods without the negative side effects of opioids are looking to be a positive growth opportunity among specialty pharmaceuticals, particularly for postoperative and chronic pain relief.
Although legal in 28 states for medicinal use, cannabis is still considered a dangerous substance in much of the country. However, many experts now believe that cannabis is a safe alternative to pharmaceuticals for relieving symptoms related to multiple illnesses.
Although the marijuana industry is comprised of some incredible companies, investors must be selective and focus on the real players.
One of the very first licensed producers and a pioneer in Canadian medical cannabis, ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) has always held to meticulous specifications in the production of its pharmaceutical grade, plant-based medicines.
InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team.
China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy.